Clinical Trial Update: Patient Centered Randomized Controlled Trial [NA]

View source ↗

Summary

A patient-centered randomized controlled trial in early-stage breast cancer has completed the study, sponsored by Icahn School of Medicine at Mount Sinai.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Early-Stage Breast Cancer | NA | Status: COMPLETED